J. D. Hollander

High-flow Nasal Cannula therapy: A feasible treatment for vulnerable older COVID-19 patients on the wards

C. Noord, R. Ruiter, G. Verhoeven, 2020 .

Predictive value of pharmacodynamic parameters of antimicrobial agents

J. D. Hollander, 1999 .

The Predictive Value of Laboratory Tests for Efficacy of Antibiotic Combination Therapy

J. Mouton, J. D. Hollander, 2007 .

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

A. Dofferhof, M. Koopmans, A. Koster, 2020, Nature Communications.

Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections

H. Endtz, H. Verbrugh, N. van den Braak, 1997, Antimicrobial agents and chemotherapy.